CD163 and neoplasm: The expression of SIRPA, LILRB1, LILRB2, Siglec1, Siglec7, Siglec9, PDCD1, CD163 and MARCO are preferentially expressed on Mono01, Mono02 and Macro03 (Figure 4i), suggesting their tumor-promoting roles.